Peptide exchange–competent class I MHC molecules produced in eukaryotic cells for rapid production of MHC multimers
Abstract
Abstract Class I MHC peptide (MHC-Ip) multimers are well-established reagents that detect antigen-specific T cells. The classical method for production of MHC-Ip multimers begins with the expression of MHC heavy chains (HCs) and β2-microglobulin (β2m) subunits as inclusion bodies in Escherichia coli and is followed by denaturant solubilization, in vitro folding in the presence of a defined peptide ligand, and purification by size exclusion chromatography. This protocol is labor intensive, difficult to scale, and represents a significant bottleneck in application of the technology. Herein, we present a novel method for the expression in eukaryotic cells of secreted peptide exchange–competent class I MHC proteins in their native conformation. In this method, expression constructs are engineered as bimolecular complexes composed of an MHC HC and a β2m molecule covalently linked at its amino terminus to an MHC-binding peptide through a flexible peptide linker containing a defined protease site. Upon proteolysis, the original peptide occupant of the MHC binding site dissociates and is easily replaced with a synthetic peptide. When leucine zippers are added to the carboxyl terminus of each subunit, protease cleavage of the linker results in a stable HC/β2m complex that can be isolated and stored for subsequent peptide loading. Using this method, we have produced homogeneous MHC-Ip complexes for 25 class I MHC alleles and demonstrated that tetramers produced in this way are equivalent to conventionally produced tetramers for T-cell staining.
Article Details
Journal Info
The Journal of Immunology
American Association of Immunologists
Authors (12)
Vasanthi Ramachandiran
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
John C Shires
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
Richard A Willis
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
Ge Bai
Donielle L Bell
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
Lixia Han
Tamara R Kazarian
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
Fred O Ede
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
Oskar Laur
Sujin Lee
Dale L Long
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,
John D Altman
Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA,